Results 81 to 90 of about 5,561 (172)

The Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial

, 2011
Host iron availability is fundamental to mucormycosis pathogenesis. The combination of liposomal amphotericin B (LAmB) and deferasirox iron chelation therapy synergistically improved survival in diabetic mice with mucormycosis. To determine the safety of
Morris, Michele I, Michele I. Morris, John R. Perfect, Fredricks, David, Brass, Eric P, Ibrahim, Ashraf S, Peter V. Chin-Hong, Eric P. Brass, Spellberg, Brad, Kontoyiannis, Dimitrios P, Ashraf S. Ibrahim, David Fredricks, Dimitrios P. Kontoyiannis, Chin-Hong, Peter V, Perfect, John R, Brad Spellberg   +15 more
core   +1 more source

Successful Deferasirox Rechallenge and Treating Through Reaction in a Patient with Challenge-Proven Mild Immediate Reaction: A Case Report

Journal of Asthma and Allergy, 2020
Mongkhon Sompornrattanaphan,1 Thanachit Krikeerati,1,2 Chamard Wongsa,1 Torpong Thongngarm,1 Kittika Yampayon3 1Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok ...
Sompornrattanaphan M, Krikeerati T, Wongsa C, Thongngarm T, Yampayon K   +4 more
doaj  

Assessing the auditory effects of oral chelation therapy drug Deferasirox in individuals with β‐thalassemia major

World Journal of Otorhinolaryngology-Head and Neck Surgery
Objective Our study aimed to investigate the ototoxicity associated with the iron chelator deferasirox in patients with β‐thalassemia major, who were receiving regular transfusion therapy, along with evaluating the data on audiological tests using ...
Balwinder S. Tiwana, Ankita Aggarwal, Sanjeev Bhagat, Harjinder Singh, Dimple Sahni, Vishav Yadav   +5 more
doaj   +1 more source

Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior

Caspian Journal of Internal Medicine, 2017
Background: Cardiac complications due to iron overload are the most common cause of death in patients with thalassemia major. The aim of this study was to compare iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and ...
Shahla Ansari, Azita Azarkeivan, Ghasem Miri-Aliabad, Saeed Yousefian, Tahereh Rostami   +4 more
doaj  

Oktaéderes Ru(III)-deferasirox komplexek szintézise és vizsgálata

, 2018
A ruténium egyes komplexei daganatos sejtekkel szemben jelentős aktivitást mutatnak. A vízben rosszul oldódó deferasirox és dekarboxi-deferasrox vaskelátorok a vas megkötésével, valamint ROS képzés hatására a rákos sejteket pusztíthatják.
Ferenczik, Gergő Tamás
core  

Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.

Mediterranean Journal of Hematology and Infectious Diseases, 2014
The long-term hematological response in a patient with 5q- syndrome after lenalidomide suspension and the further improvement observe while she was receiving deferasirox alone is reported.
Pasquale Niscola
doaj  

Deferasirox 6 months after allo-HSCT in AML/MDS: a prospective propensity-matched study. [PDF]

Blood Adv
Buono R, Huynh A, Forcade E, Labussière H, Ceballos P, Cornillon J, Cabrera Q, D'Aveni M, Robin M, Devillier R, Raus N, Michallet M.   +11 more
europepmc   +1 more source

Busulfan pharmacokinetics in adults - a real-world evaluation of intra-individual variability and the impact of obesity and deferasirox. [PDF]

Bone Marrow Transplant
Langebrake C, Wansing EA, Janson D, Wolschke C, Lueck C, Ayuk F, Kröger NM, Dadkhah A.   +7 more
europepmc   +1 more source

Triple Iron Chelation in Transfusion Dependent Thalassemia: A Case Report. [PDF]

J Clin Med
Njue L, Häfliger E, Rovó A.
europepmc   +1 more source

Dual oral iron chelation with deferasirox and deferiprone in transfusion-dependent β-thalassemia: a narrative review of efficacy, safety, and practical application. [PDF]

Ann Hematol
James V, Emeghebo KI.
europepmc   +1 more source